慢性乙型肝炎患者血红蛋白与肝细胞脂肪变的相关性及其临床价值

王鹏; 张志侨; 吕国涛; 王功遂; 陈晓巧; 明朗; 郑翀; 陈乐无; 谢秋里; 何杰雄; 黄勇

doi:10.3969/j.issn.1001-5256.2017.07.014

慢性乙型肝炎患者血红蛋白与肝细胞脂肪变的相关性及其临床价值

DOI: 10.3969/j.issn.1001-5256.2017.07.014

佛山市顺德区第一人民医院感染性疾病科

基金项目:

广东省卫生厅立项资助课题(A2016450;A2013695)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 2487
- HTML全文浏览量: 19
- PDF下载量: 443
- 被引次数: 0
出版历程
- 收稿日期: 2017-01-13
- 出版日期: 2017-07-20

Clinical value of hemoglobin and its association with hepatocyte steatosis in chronic hepatitis B patients

Department of Infectious Diseases, The First People's Hospital of Shunde

Research funding:

摘要

摘要: 目的研究慢性乙型肝炎（CHB）患者血红蛋白和肝细胞脂肪变的相关性及其临床价值。方法回顾性收集2006年1月-2014年12月在佛山市顺德区第一人民医院住院行肝穿刺活组织检查的1580例CHB患者的临床和病理资料,其中216例（13.67%）患者合并肝细胞脂肪变（肝细胞脂肪变组）,1364例（86.33%）为非肝细胞脂肪变患者（非肝细胞脂肪变组）。按血红蛋白水平由低到高分为1组、2组和3组,对3组的临床和病理特征进行分析和比较。计量资料2组间比较采用t检验,多组间比较采用方差分析;等级资料2组间比较采用Mann-Whitney U检验,多组间比较采用Kruskal-Wallis H检验;计数资料组间比较采用χ2检验。两变量间相关性采用Spearman秩相关分析。采用单因素logistic回归分析和多因素逐步logistic回归分析探索肝细胞脂肪变的影响因素。结果 BMI、收缩压、舒张压、尿酸、TC、LDL和HBV DNA载量在不同血红蛋白水平的组间差异有统计学意义（F值分别为12.718、3.024、4.026、4.624、38、276、28.108、7.358,P...
- 肝炎,乙型,慢性 /
- 血红蛋白类 /
- 脂肪肝 /
- 回归分析
Abstract: Objective To investigate the clinical value of hemoglobin and its association with hepatocyte steatosis in chronic hepatitis B (CHB) patients.Methods A retrospective analysis was performed for the clinical and pathological data of 1580 CHB patients who were hospitalized in The First People's Hospital of Shunde from January 2006 to December 2014 and underwent liver biopsy, among whom 216 (13.67%) had hepatocyte steatosis (hepatocyte steatosis group) and 1364 had no hepatocyte steatosis (non-hepatocyte steatosis group) .The patients were divided into groups 1, 2, and 3 according to hemoglobin level, and the clinical and pathological features were analyzed and compared between the three groups.The t-test was used for comparison of continuous data between group;a one-way analysis of variance was used for comparision between multiple groups.The Mann-Whitney U test was used for ranked data between groups.The Kruskal-wallis H test was used for ranked data between multiple groups;the chi-square test was used for comparison of categorical data between groups.Spearman correlation analysis was also performed to determine the correlation between two variables.Univariate logistic regression analysis and multivariate stepwise regression analysis were used to identify the influencing factors for hepatocyte steatosis.Results Body mass index (BMI) , systolic pressure, diastolic pressure, uric acid, total cholesterol, low-density lipoprotein, and HBV DNA load increased with the increase in hemoglobin level (F=12.718, 3.024, 4.026, 4.624, 38.276, 28.108, 7.358, all P<0.05) .The incidence rates of hepatocyte steatosis in groups 1, 2, and 3 were 7.59%, 11.76%, and 21.67%, respectively (χ2=44.23, P<0.05) .Hemoglobin was positively correlated with hepatic steatosis (rs=0.211, P<0.001) .The multivariate logistic regression analysis showed that hemoglobin (odds ratio [OR]=1.066, P<0.05) , BMI (OR=1.576, P<0.05) , age (OR=1.041, P<0.05) , sex (OR=0.261, P<0.05) , aspartate aminotransferase (OR=0.987, P<0.05) , triglyceride (OR=1.690, P<0.05) , and uric acid (OR=1.006, P<0.05) were independent influencing factors for hepatocyte steatosis in CHB patients.The area under the receiver operating characteristic curve was 0.852 (95% confidence interval [CI]:0.811-0.893, P<0.01) for BMI, 0.701 (95% CI:0.662-0.740, P<0.01) for low-density lipoprotein, 0.694 (95% CI:0.653-0.734, P<0.01) for triglyceride, 0.689 (95% CI:0.650-0.728, P<0.01) for total cholesterol, 0.675 (95% CI:0.637-0.714, P<0.01) for hemoglobin, 0.654 (95% CI:0.617-0.691, P<0.01) for age, 0.619 (95%CI:0.575-0.662, P<0.01) for uric acid, and 0.612 (95% CI:0.569-0.655, P<0.01) for blood glucose.Conclusion CHB patients with a high hemoglobin level tend to develop hepatocyte steatosis, and hemoglobin may be an independent influencing factor for hepatocyte steatosis in CHB patients.A high hemoglobin level has a certain value in predicting hepatocyte steatosis and awaits further research.
- hepatitis B, chronic /
- hemoglobins /
- fatty liver /
- regression analysis

HTML全文

参考文献(16)

[1]LU FM, ZHUANG H.Management of hepatitis B in China[J].Chin Med J, 2009, 122 (1) :3-4.

[2]LI N, LI HB, ZHU L, et al.Diagnostic value of fibrinogen and routine blood tests for hepatitis B[J].Int J Virol, 2016, 23 (1) :38-40. (in Chinese) 李娜, 李宏斌, 朱蕾, 等.纤维蛋白原和血常规检测对乙型肝炎的诊断价值[J].国际病毒学杂志, 2016, 23 (1) :38-40.

[3]BELLENTANI S, SCAGLIONI F, MARINO M, et al.Epidemiology of non-alcoholic fatty liver disease[J].Dig Dis Dis, 2010, 28 (1) :155-161.

[4]MACHADO MV, OLIVEIRA AG, CORTEZ-PINTO H.Hepatic steatosis in hepatitis B virus infected patients:Meta-analysis of risk factors and comparison with hepatitis C infected patients[J].JGastroenterol Hepatol, 2011, 26 (9) :1361-1367.

[5]SUNG KC, RYAN MC, WILSON AM.The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects[J].Atherosclerosis, 2009, 203 (2) :581-586.

[6]JIN X, CHEN YP, YANG YD, et al.Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B[J].PLo S One, 2012, 7 (3) :e34198.

[7]TRAK-SMAYRA V, DARGERE D, NOUN R, et al.Serum proteomic profiling of obese patients:correlation with liver pathology and evolution after bariatric surgery[J].Gut, 2009, 58 (6) :825-832.

[8]XU L, XU CF, YU CH, et al.Haemoglobin and non-alcoholic fatty liver disease:further evidence from a population-based study[J].Gut, 2009, 58 (12) :1706-1707.

[9]YU C, XU C, XU L, et al.Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease[J].J Hepatol, 2012, 56 (1) :241-247.

[10]Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :Ⅰ-ⅩⅥ. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010版) [J].临床肝胆病杂志, 2011, 27 (1) :Ⅰ-ⅩⅥ.

[11]KLEINER DE, BRUNT EM.Nonalcoholic fatty liver disease:pathologic patterns and biopsy evaluation in clinical research[J].Semin Liver Dis, 2012, 32 (1) :3-13.

[12]YILMAZ Y, SENATES E, AYYILDIZ T, et al.Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome[J].Eur J Clin Invest, 2011, 42 (4) :411-418.

[13]CAI W, ZHANG B, MIAO L, et al.Prospective cohort study of the predictive value of hemoglobin levels for non-alcoholic fatty liver disease[J].Chin J Hepatol, 2014, 22 (3) :200-204. (in Chinese) 蔡雯, 张蓓, 苗蕾, 等.血红蛋白浓度预测非酒精性脂肪性肝病的前瞻性队列研究[J].中华肝脏病杂志, 2014, 22 (3) :200-204.

[14]SU DZ, AI LY, WANG XH, et al.Study on the risk of non-alcoholic fatty liver disease caused by high hemoglobin level:the impact of gender[J].Chin Hepatol, 2013, 18 (11) :728-732. (in Chinese) 苏大芝, 艾罗燕, 王晓晗, 等.不同性别高血红蛋白水平对非酒精性脂肪性肝病发生风险的影响[J].肝脏, 2013, 18 (11) :728-732.

[15]LIU XT, TAO LX, YANG K, et al.Association between hemoglobin and metabolic syndrome:a five-year follow-up[J].J Capit Med Univ, 2016, 37 (4) :509-512. (in Chinese) 刘相佟, 陶丽新, 杨昆, 等.血红蛋白与成人代谢综合征及其组分关联性的五年队列研究[J].首都医科大学学报, 2016, 37 (4) :509-512.

[16]ZHANG ZG, XUE L, ZHANG YX, et al.Analysis of the prevalence of nonalcoholic fatty liver disease in uygur civil servants in urumqi[J].Modern Prevent Med, 2012, 39 (8) :1955-1957. (in Chinese) 张泽高, 薛黎, 张跃新, 等.乌鲁木齐市公务员非酒精性脂肪肝调查[J].现代预防医学, 2012, 39 (8) :1955-1957.

施引文献

资源附件(0)

访问统计